You are here: Home » Companies » News
Business Standard

PAG-led consortium to invest $70 mn for controlling stake in Anjan Drug

Private equity fund PAG is picking up a controlling stake in active pharmaceutical ingredient (API) maker Anjan Drug for over USD 70 million, sources said on Monday

Pharma industry

Press Trust of India  |  Mumbai 

paracetamol, pharma, drugs, medicine, health

Private equity fund PAG is picking up a controlling stake in active pharmaceutical ingredient (API) maker Anjan Drug for over USD 70 million, sources said on Monday.

Earlier in the day, the Asia-focused PE firm said it is partnering with CX Partners and Samara Capital to pick a controlling stake in the Chennai-based Anjan Drug. It, however, did not disclose the deal consideration.

Activity in the API space is attracting attention lately as India tries to veer away from China for its API requirements, and also as the world looks for other options beyond Chinese makers as part of the supply chain shifts.

According to the source, the PAG-led consortium will be paying USD 70-80 million for around 70 per cent stake in Anjan, which was founded by C Kalaichelvan in 1990.

Anjan is a leading supplier of active drug ingredients in the central nervous system therapy segment to some of the world's largest pharmaceutical companies, in markets including the US, Canada, Brazil and Europe, according to a press statement issued by PAG.

The acquisition is part of the PAG-led consortium's strategy to create a best-in-class platform for the development and production of bulk drug ingredients, it said.

The partnership is a key first step in PAG's plan to create the preeminent platform for Indian API, its Managing Director and Head India (Private Equity) Nikhil Srivastava said.

He said Anjan has a strong customer base in some of the world's largest and best-regulated pharmaceuticals markets and maintains the highest-quality manufacturing standards.

"On behalf of the consortium, we look forward to working with Kalaichelvan and the company's management to help them continue on their path to growth," he added.

The PAG-led consortium is moving towards the creation of a platform to tap into the consolidation opportunities in India's high-growth API manufacturing industry, as per the statement.

Srivastava said the Indian API market is an attractive opportunity and well positioned for the future.

PAG is currently investing out of its USD 6 billion PAG Asia III buyout fund and has declared plans to invest up to USD 1 billion in India over the next few years, as per the statement.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, October 12 2020. 21:45 IST